Cell and Gene Therapy

Cell and gene therapies are a transformative new category of medicines whose full potential is only just beginning to emerge. Standard, small-molecule treatments are produced in a standardised fashion, and most are relatively short-lived within the body. 

Cell and gene therapies are different. They involve extracting cells, protein or genetic material (DNA) from the patient (or a donor), and altering them to provide a highly personalised therapy, which is re-injected into the patient. Cell and gene therapies may offer longer-lasting effects than traditional medicines. They have the potential to address complex diseases, such as motor neurone disease, and many rare disorders for which there are no effective treatments.

CGT icon

 

 

BIA and FIRM directories

The BIA and FIRM have agreed to work together to enable Japanese companies in regenerative medicine and cell and gene therapy and related industry to collaborate with UK companies and vice versa. To improve collaboration, the BIA and FIRM are making available to each other a directory of members engaged in regenerative medicine, enabling global access to talent, expertise, education and partnerships. Japan has a history of innovation in regenerative medicine and commitment to a future of global scientific excellence. There is a strong track-record of partnership working in regenerative medicine between UK and Japanese companies. We hope that this shared directory will enable Japanese and UK companies to work cooperatively to solve problems and accelerate mutual commercial outcomes that generate health and wealth gains for our countries.

BIA directory

 

FIRM Directory

To note you need to be a BIA member to access the FIRM directory.

FIRM Directory

 

Leading Innovation|The UK's ATMP Landscape

The Alliance for Regenerative Medicine (ARM) and the BioIndustry Association (BIA) have published a report setting out the scope of the UK’s robust and growing Advanced Therapy Medicinal Products (ATMPs) sector which includes the development of potentially transformative cell and gene therapies.

Report BIA ARM

Cell and Gene Therapies Explained

To learn more about Cell and Gene Therapies, download our Cell and Gene Therapies Explained: A guide to cell and gene therapy and UK excellence in the field, featuring case studies from BIA members Cell Medica, Immunocore, Nightstar Therapeutics, Horizon Discovery and Oxford Biomedica. You can download the report below.

Cell and Gene Therapy Explained

 

Celebrating UK Bioscience | Cell and Gene Therapy

We have also produced a video alongside the explainer which features case studies from Oxford Biomedica and the Cell and Gene Therapy Catapult.  This video explores BIA member companies working on researching, developing and manufacturing the very latest cell and gene therapies. 

Celebrating UK Bioscience | Cell and Gene Therapy
Celebrating UK Bioscience | Cell and Gene Therapy Cell and Gene therapies are at the forefront of modern medicine - harnessing the power of the human immune system to fight cancer and editing genes to cure disease where it starts. This video forms part of a BIA campaign, Celebrating UK Bioscience, looking at the work being undertaken by UK biotech companies in the Cell and Gene therapy space - from research through to manufacturing.

We would like to thank the BIA's Cell and Gene Therapy Advisory Committee for supporting the production of the video and guide. 

Add to my favourites